Functions of interleukin-34 and its emerging association with rheumatoid arthritis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functions of interleukin-34 and its emerging association with rheumatoid arthritis
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume 149, Issue 4, Pages 362-373
Publisher
Wiley
Online
2016-08-23
DOI
10.1111/imm.12660
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis
- (2016) Shao-Lai Zhou et al. HEPATOLOGY
- Sarilumab for the treatment of rheumatoid arthritis
- (2016) Simon Cooper Immunotherapy
- Efficacy and Safety of Subcutaneous and Intravenous Loading Dose Regimens of Secukinumab in Patients with Active Rheumatoid Arthritis: Results from a Randomized Phase II Study
- (2016) W. Tlustochowicz et al. JOURNAL OF RHEUMATOLOGY
- Interleukin 34 Upregulation Contributes to the Increment of MicroRNA 21 Expression through STAT3 Activation Associated with Disease Activity in Rheumatoid Arthritis
- (2016) S. Yang et al. JOURNAL OF RHEUMATOLOGY
- IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future
- (2015) Go Woon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Syndecan-1 regulates the biological activities of interleukin-34
- (2015) Aude I. Segaliny et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer
- (2015) Si Ming Man et al. CELL
- Predictors of response to TNF-α antagonist therapy in Chinese rheumatoid arthritis
- (2015) Rui Ding et al. CLINICAL RHEUMATOLOGY
- Interleukin-34 sustains inflammatory pathways in the gut
- (2015) Eleonora Franzè et al. CLINICAL SCIENCE
- Interleukin 34: a new modulator of human and experimental inflammatory bowel disease
- (2015) Stephanie Zwicker et al. CLINICAL SCIENCE
- CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
- (2015) Carola H Ries et al. CURRENT OPINION IN PHARMACOLOGY
- IL-34- and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1α
- (2015) Etienne D. Foucher et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells
- (2015) Eleonora Franzè et al. Journal of Crohns & Colitis
- Role for cFMS in maintaining alternative macrophage polarization in SIV infection: implications for HIV neuropathogenesis
- (2015) Lindsey Gerngross et al. Journal of Neuroinflammation
- Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis
- (2015) Mark C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Interleukin-34: A Potential Diagnostic and Therapeutic Target for Rheumatoid Arthritis
- (2015) W. HE et al. JOURNAL OF RHEUMATOLOGY
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- (2015) K. Pavelka et al. JOURNAL OF RHEUMATOLOGY
- The IL-23–IL-17 axis in inflammatory arthritis
- (2015) Erik Lubberts Nature Reviews Rheumatology
- Intra-articular administration of an antibody against CSF-1 receptor reduces pain-related behaviors and inflammation in CFA-induced knee arthritis
- (2015) P.A. Alvarado-Vazquez et al. NEUROSCIENCE LETTERS
- New insights into the resolution of inflammation
- (2015) Derek Gilroy et al. SEMINARS IN IMMUNOLOGY
- Novel therapeutic targets in rheumatoid arthritis
- (2015) Marije I. Koenders et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-Analysis of Randomized Trials
- (2015) Niels Graudal et al. ARTHRITIS CARE & RESEARCH
- Toll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis
- (2015) Trudy McGarry et al. ARTHRITIS RESEARCH & THERAPY
- Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis
- (2015) Ming Zong et al. ARTHRITIS RESEARCH & THERAPY
- IL-34 SuppressesCandida albicansInduced TNFαProduction in M1 Macrophages by Downregulating Expression of Dectin-1 and TLR2
- (2015) Rong Xu et al. Journal of Immunology Research
- Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations
- (2014) Sébastien Bihorel et al. AAPS Journal
- The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy
- (2014) Philip G Conaghan et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular control of monocyte development
- (2014) Rachael L. Terry et al. CELLULAR IMMUNOLOGY
- Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells
- (2014) Yaming Wang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Transcriptomic analysis of mononuclear phagocyte differentiation and activation
- (2014) David A. Hume et al. IMMUNOLOGICAL REVIEWS
- Anti-TNF therapy: past, present and future
- (2014) C. Monaco et al. INTERNATIONAL IMMUNOLOGY
- Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment
- (2014) Aude I. Ségaliny et al. INTERNATIONAL JOURNAL OF CANCER
- IL-34 Is Associated with Obesity, Chronic Inflammation, and Insulin Resistance
- (2014) Eun-Ju Chang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Developing new oral targeted therapies for RA can be challenging
- (2014) Roy M. Fleischmann Nature Reviews Rheumatology
- Alternative pathways of osteoclastogenesis in inflammatory arthritis
- (2014) Iannis E. Adamopoulos et al. Nature Reviews Rheumatology
- Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis
- (2014) Paul Emery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-34 Restores Blood–Brain Barrier Integrity by Upregulating Tight Junction Proteins in Endothelial Cells
- (2014) Shijie Jin et al. PLoS One
- Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis
- (2014) Sung Hae Chang et al. RHEUMATOLOGY INTERNATIONAL
- Bone- and Cartilage-Protective Effects of a Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor in Experimental Arthritis
- (2014) Myew-Ling Toh et al. Arthritis & Rheumatology
- IL-32 with potential insights into rheumatoid arthritis
- (2013) Wang-Dong Xu et al. CLINICAL IMMUNOLOGY
- Transcriptional profiling and pathway analysis of CSF-1 and IL-34 effects on human monocyte differentiation
- (2013) Ruteja A. Barve et al. CYTOKINE
- Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes
- (2013) Seon-Yeong Lee et al. IMMUNOLOGY
- Receptor-type Protein-tyrosine Phosphatase ζ Is a Functional Receptor for Interleukin-34
- (2013) Sayan Nandi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Elevated Serum and Synovial Fluid Levels of Interleukin-34 in Rheumatoid Arthritis: Possible Association with Disease Progression via Interleukin-17 Production
- (2013) Ye Tian et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- CSF-1 receptor-mediated differentiation of a new type of monocytic cell with B cell-stimulating activity: its selective dependence on IL-34
- (2013) F. Yamane et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Increased Levels of Interleukin 34 in Serum and Synovial Fluid Are Associated with Rheumatoid Factor and Anticyclic Citrullinated Peptide Antibody Titers in Patients with Rheumatoid Arthritis
- (2013) S.-J. Moon et al. JOURNAL OF RHEUMATOLOGY
- Angiogenesis and Its Therapeutic Opportunities
- (2013) So Young Yoo et al. MEDIATORS OF INFLAMMATION
- IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFNγ
- (2013) Etienne D. Foucher et al. PLoS One
- The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation
- (2013) Elisabeth A. Boström et al. PLoS One
- IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes
- (2013) F. Ciccia et al. RHEUMATOLOGY
- Human IL-34 and CSF-1 Establish Structurally Similar Extracellular Assemblies with Their Common Hematopoietic Receptor
- (2013) Jan Felix et al. STRUCTURE
- The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1
- (2012) Heli Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation
- (2012) Sayan Nandi et al. DEVELOPMENTAL BIOLOGY
- IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia
- (2012) Yaming Wang et al. NATURE IMMUNOLOGY
- TGF-β induced by interleukin-34-stimulated microglia regulates microglial proliferation and attenuates oligomeric amyloid β neurotoxicity
- (2012) Di Ma et al. NEUROSCIENCE LETTERS
- Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice
- (2012) Y. Nakamichi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for the Dual Recognition of Helical Cytokines IL-34 and CSF-1 by CSF-1R
- (2012) Xiaolei Ma et al. STRUCTURE
- Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis
- (2012) Seung-Jun Hwang et al. ARTHRITIS RESEARCH & THERAPY
- Interleukin-34 Selectively Enhances the Neuroprotective Effects of Microglia to Attenuate Oligomeric Amyloid-β Neurotoxicity
- (2011) Tetsuya Mizuno et al. AMERICAN JOURNAL OF PATHOLOGY
- Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients
- (2011) M Chemel et al. ANNALS OF THE RHEUMATIC DISEASES
- Angiogenesis in rheumatoid arthritis: A disease specific process or a common response to chronic inflammation?
- (2011) Alessandra Marrelli et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
- (2011) Zhenhua Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- IL-33: a promising therapeutic target for rheumatoid arthritis?
- (2011) Feng-Lai Yuan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Consensus Substrate Sequence for Protein-tyrosine Phosphatase Receptor Type Z
- (2011) Akihiro Fujikawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Critical Role of IL-34 in Osteoclastogenesis
- (2011) Zhi Chen et al. PLoS One
- Nonresolving Inflammation
- (2010) Carl Nathan et al. CELL
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation
- (2010) T Chihara et al. CELL DEATH AND DIFFERENTIATION
- Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood
- (2010) Hiroyuki Eda et al. CYTOKINE
- Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1 ), interleukin-34 (IL-34 ), and CSF-1 receptor genes and gene products
- (2010) Valerie Garceau et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells
- (2010) Suwen Wei et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis
- (2010) Marc Baud'Huin et al. JOURNAL OF PATHOLOGY
- Targeting interleukin-21 in rheumatoid arthritis
- (2010) Feng-Lai Yuan et al. MOLECULAR BIOLOGY REPORTS
- Cell adhesion: integrating cytoskeletal dynamics and cellular tension
- (2010) J. Thomas Parsons et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells
- (2010) Melodie L. Knowlton et al. PLoS One
- Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts
- (2010) Hiroyuki Eda et al. RHEUMATOLOGY INTERNATIONAL
- Blocking Interleukin-1 in Rheumatic Diseases
- (2009) Raphaela Goldbach-Mansky Annals of the New York Academy of Sciences
- Colony-Stimulating Factor-1 Receptor Inhibitors for the Treatment of Cancer and Inflammatory Disease
- (2009) Sharmila Patel et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A systematic review and meta-analysis of the efficacy and safety of adalimumab for treating rheumatoid arthritis
- (2009) Astrid Wiens et al. RHEUMATOLOGY INTERNATIONAL
- EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages
- (2009) Lina Covaleda et al. VIROLOGY
- Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
- (2008) J Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
- (2008) E C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- CSF-1 receptor structure/function in MacCsf1r-/- macrophages: regulation of proliferation, differentiation, and morphology
- (2008) Wenfeng Yu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats
- (2008) J. G. Conway et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome
- (2008) H. Lin et al. SCIENCE
- The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model
- (2007) Hiroaki Ohno et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search